GSK shares surge as US judge dismisses Zantac cancer claims

Shares in drug firms GlaxoSmithKline and Sanofi surged after a US judge dismissed thousands of lawsuits claiming that the heartburn drug Zantac caused cancer. GSK’s shares jumped as much as 14% in early trading, while Sanofi’s stock jumped nearly 6% in mid-morning trading. The US district judge…#gsk #russmould #westpalmbeach #ndma #sanofi #robinrosenberg #dameemmawalmsley #haleon #florida #ajbell
Source: Reuters: Health - Category: Consumer Health News Source Type: news